Akston Biosciences Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Series F
  • Latest Deal Amount
  • $11.3M
Latest Deal Amount
  • Investors
  • 6

Akston Biosciences General Information

Description

Developer of fusion proteins intended to develop and manufacture new classes of biologic therapeutics to prevent diabetes. The company's insulin drug can be used in autoimmune type 1 diabetes prevention, ultra-long-acting insulin therapy and oncology over hypoglycemia-free glucose control in diabetic mice with a single injection, enabling doctors to improve glucose control, reduce complications and eliminate hypoglycemia risk for human and animal health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 100 Cummings Center
  • Suite 454C
  • Beverly, MA 01915
  • United States
+1 (978) 000-0000

Akston Biosciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akston Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series F) 07-Jun-2021 $11.3M 000.00 00000 Completed Generating Revenue
8. Later Stage VC (Series E) 11-May-2020 00.000 000.00 000.00 Completed Generating Revenue
7. Debt - PPP 07-Apr-2020 00000 000.00 Completed Generating Revenue
6. Grant 01-Jul-2019 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 17-May-2018 00.00 000.00 000.00 Completed Generating Revenue
4. Debt - General 16-Mar-2017 00.00 00.00 Completed Generating Revenue
3. Later Stage VC (Series C) 22-Aug-2016 00.00 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 21-May-2015 $1.6M $2.3M 000.00 Completed Generating Revenue
1. Angel (individual) 14-Feb-2013 $700K $700K 00.00 Completed Generating Revenue
To view Akston Biosciences’s complete valuation and funding history, request access »

Akston Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series E 000,000 00.000000 00.00 000.0 000.0 00 000.0 00.000
Series D 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series C 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.00
Series B 121,934 $0.000001 $1.06 $13.3 $13.3 1x $13.3 6.48%
Series A 139,075 $0.000001 $0.6 $7.5 $7.5 1x $7.5 7.39%
To view Akston Biosciences’s complete cap table history, request access »

Akston Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Todd Zion Ph.D Co-Founder, Chairman, President & Chief Executive Officer
James Herriman Vice President, Operations & Board Member
Thillainayagam Sathiyaseelan Ph.D Vice President, Quality and Regulatory Affairs & Board Member
Thomas Lancaster Ph.D Vice President, Research & Development and Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Akston Biosciences Board Members (6)

Name Representing Role Since
James Herriman Akston Biosciences Vice President, Operations & Board Member 000 0000
Lovick Cannon Ph.D Self Board Member 000 0000
Robyn Davis Self Board Member 000 0000
Thillainayagam Sathiyaseelan Ph.D Akston Biosciences Vice President, Quality and Regulatory Affairs & Board Member 000 0000
Thomas Lancaster Ph.D Akston Biosciences Vice President, Research & Development and Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Akston Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akston Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boston Harbor Angels Angel Group Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
The National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Founders Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »